Unichem Laboratories Ltd. — Major Shareholding Notification 2023

Sep 21, 2023

==> picture [190 x 43] intentionally omitted <==

September 21, 2023

BSE Ltd. National Stock Exchange India Limited, Exchange Phiroze Jeejeebhoy Towers Plaza, C-1, Block-G, Dalal Street Bandra Kurla Complex, Mumbai 400 023 Bandra – (East). Mumbai-400051. Scrip Code : 506690 Scrip Code: UNICHEMLAB

Dear Sirs

• Re: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“SEBI LODR Regulations”) by Unichem Laboratories Limited (“Company”).

• Sub: Further acquisition of 1,35,79,571 equity shares of Rs. 2/- each representing 19.29% of the paid-up equity share capital of the Company by Ipca Laboratories Limited under open offer.

Further to our intimation dated August 2, 2023 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 about sale of 2,35,01,440 fully paid-up equity shares of Rs. 2/- each of the Company, representing 33.38% of its paid-up equity share capital @ Rs. 402.25 per share aggregating to Rs. 945.35 Crores by Dr. Prakash A. Mody, one of the Promoter of the Company to Ipca Laboratories Limited (Acquirer), we now wish to inform you as under:

1. Consequent upon agreeing to acquire the above equity shares, the Acquirer had made an Open Offer to the public shareholders of the Company to acquire from them upto 26% of the fully diluted outstanding equity share capital of the company at a price @ Rs. 440/- per equity share aggregating to Rs. 805.44 crores, under the relevant provisions of SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011.

2. The said Open Offer closed on September 8, 2023.

3. The Acquirer has accepted 1,35,79,571 equity shares of Rs. 2/- each validly tendered in the said open offer by the public shareholders of the Company @ Rs. 440 per equity share aggregating to Rs. 597.50 crores (plus brokerage, STT and other levies) and representing 19.29% of the paid-up equity share capital of the Company.

==> picture [189 x 31] intentionally omitted <==

Registered Office: Unichem Bhavan, Prabhat Estate, Off S. V. Road Jogeshwari (West), Mumbai – 400 102, Maharashtra, India.

==> picture [190 x 43] intentionally omitted <==

1. With this further acquisition of shares tendered in the open offer, the Acquirer now holds 3,70,81,011 fully paid-up equity shares of Rs. 2/- each of the Company, representing 52.67% of paid-up share capital of the company. In view of this, the Company (Unichem Laboratories Limited) has now become subsidiary of the Acquirer.

2. This acquisition by the Acquirer does not fall within the related party transaction. This acquisition is pursuant to open offer made under SEBI (SAST) Regulations, 2011.

3. The following Wholly Owned Subsidiaries of the Company have now become subsidiaries of the Ipca Laboratories Ltd:

4. a. Niche Generics Ltd., UK

5. b. Unichem SA Pty Ltd., South Africa

6. c. Unichem Farmaceutica Do Brasil Ltda, Brazil

7. d. Unichem Pharmaceuticals USA Inc., USA

8. e. Unichem Laboratories Ltd., Ireland

9. f. Unichem (China) Pvt. Ltd., China

Kindly take this information on record.

Yours faithfully

For UNICHEM LABORATORIES LIMITED PRADEEP Digitally signed by PRADEEP BHANDARI BHANDARI Date: 2023.09.21 15:59:23 +05'30' PRADEEP BHANDARI

Head – Legal & Company Secretary

==> picture [189 x 31] intentionally omitted <==

Registered Office: Unichem Bhavan, Prabhat Estate, Off S. V. Road Jogeshwari (West), Mumbai – 400 102, Maharashtra, India.